What is the pharmacological treatment of non-bacterial prostatitis, also known as Chronic Pelvic Pain Syndrome (CPPS) or Chronic Prostatitis (CP)/Chronic Pelvic Pain Syndrome (CPPS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The pharmacological treatment of non-bacterial prostatitis primarily involves a multimodal approach, including alpha-blockers, anti-inflammatory medications, and muscle relaxants, as these therapies have been shown to provide relief for a subset of patients, although the response can be unpredictable 1. When managing non-bacterial prostatitis, also known as chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), it's essential to consider the patient's specific symptoms and how they may align with or differ from those of interstitial cystitis/bladder pain syndrome (IC/BPS), as the treatment approaches can overlap 1.

Key Treatment Components

  • Alpha-blockers, such as tamsulosin, alfuzosin, or silodosin, are used to relax the smooth muscle of the prostate and bladder neck, thereby improving urinary flow and reducing symptoms.
  • Nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen can help reduce inflammation and pain associated with the condition.
  • Muscle relaxants, including baclofen or diazepam, may be beneficial for patients with significant pelvic floor muscle tension.
  • Some patients may also respond to neuropathic pain medications such as pregabalin or amitriptyline.

Treatment Approach

Treatment typically involves a trial of these medications for 4-6 weeks before assessing the patient's response, with some patients requiring longer therapy 1.

Lifestyle Modifications

In addition to pharmacological treatment, advising patients on lifestyle modifications such as adequate hydration and avoiding bladder irritants like caffeine, alcohol, and spicy foods can complement the treatment approach.

Considerations

It's crucial to recognize that the diagnosis of IC/BPS should be considered in men whose pain is perceived to be related to the bladder, and the treatment approach can include established IC/BPS therapies as well as other therapies more specific to CP/CPPS, as certain men may have symptoms that meet criteria for both conditions 1.

From the Research

Pharmacological Treatment of Non-Bacterial Prostatitis

The pharmacological treatment of non-bacterial prostatitis involves various medications, including:

  • Alpha-blockers: These medications have been shown to improve symptoms in men with chronic non-bacterial prostatitis 2
  • Bioflavonoids: Although bioflavonoids have been reported to improve symptoms, a study found no significant improvement in symptoms compared to alpha-blockers 2
  • Anti-inflammatory agents: These medications may be used in combination with alpha-blockers or other medications to reduce inflammation and improve symptoms 3
  • Muscle relaxants: These medications may be used in combination with alpha-blockers and anti-inflammatory agents to reduce muscle spasms and improve symptoms 3

Treatment Approaches

Different treatment approaches have been studied, including:

  • Monotherapy: Using a single medication, such as an alpha-blocker, to treat symptoms 3
  • Combination therapy: Using multiple medications, such as an alpha-blocker, anti-inflammatory agent, and muscle relaxant, to treat symptoms 3
  • Stepwise approach: Starting with antibiotics, followed by bioflavonoids, and then alpha-blockers, to reduce symptoms 3

Efficacy of Treatments

The efficacy of these treatments varies, with:

  • Alpha-blockers showing significant improvement in symptoms in most men with chronic non-bacterial prostatitis 2
  • Bioflavonoids showing no significant improvement in symptoms compared to alpha-blockers 2
  • Combination therapy showing no significant advantages over monotherapy 3
  • Stepwise approach showing effective reduction in symptoms for up to 1 year in patients with chronic prostatitis 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Identification, pharmacologic considerations, and management of prostatitis.

The American journal of geriatric pharmacotherapy, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.